One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy
Kim, Daniel Seung, Chu, Emily L., Keamy-Minor, Emily E., Paranjpe, Ishan Dhananjay, Tang, Wilson L., O’Sullivan, Jack W., Desai, Yaanik B., Liu, Michael B., Munsey, Elise, Hecker, Kimberly, Cuenco, Isabella, Kao, Beth, Bacolor, Ellen, Bonnett, Colleen, Linder, Andrea, Lacar, Kathleen, Robles, Nancy, Lamendola, Cindy, Smith, Allysonne, Knowles, Joshua W., Perez, Marco V., Kawana, Masataka, Sallam, Karim I., Weldy, Chad S., Wheeler, Matthew T., Parikh, Victoria N., Salisbury, Heidi, Ashley, Euan A.
Published in Frontiers in cardiovascular medicine (30.08.2024)
Published in Frontiers in cardiovascular medicine (30.08.2024)
Get full text
Journal Article